Archives

by in
Entry Author Date Location
NanoBio, U-M Nab $1.5M to Treat Combat Injuries 10/12/10 Detroit
Sunesis Adds $15.5M 10/01/10 San Francisco
Rigel Nabs $25M From AstraZeneca 09/29/10 San Francisco
Sanford-Burnham Gets $21M Grant 09/28/10 San Diego
Oncothyreon Raises $14.9M 09/24/10 Seattle
Infinia, InnovaTek Win U.S. Grants 09/16/10 Seattle
ZymoGenetics Reaches the End, Stratos Genomics Nabs $4M, Children’s New Ventilator, & More Seattle-Area Life Sciences News 09/09/10 Seattle
Swedish Names Chief Scientist 09/08/10 Seattle
The Feds Need to Start Supporting Early-Stage Drug Development 09/02/10 Seattle
Complete Genomics Adds $39M 08/19/10 San Francisco
Nuon Adds $10M Debt, Options 08/12/10 San Francisco
EE Tech Gets $280K; Army Backing 08/04/10 Seattle
Dendreon Misses Wall Street’s (Already Low) Expectations for Provenge Sales 08/03/10 Seattle
Dendreon Watchers: Buckle Up for Action in First Quarterly Report With Actual Sales 08/03/10 Seattle
Complete Genomics Seeks IPO 08/02/10 San Francisco
LS9 Reveals Key Biofuel Genes, Onyx Drug Passes Big Trial, Solazyme Seeks First-Mover Edge, & More Bay Area Life Sciences News 07/30/10 San Francisco
Omeros Lines Up $40M Financing 07/29/10 Seattle
Marina Gets RNAi Delivery Tools for $5M 07/28/10 Seattle
Gilead Borrowing $2.2B 07/26/10 San Francisco
Biotech on a Shoestring? There’s a Better Way 07/26/10 San Diego
Genzyme Stock Surges 15 Percent on Sanofi Buyout Speculation 07/23/10 Boston
MDRNA Does Reverse Stock Split 07/21/10 Seattle
Oncothyreon Lines Up $20M 07/07/10 Seattle
Motricity Completes IPO, Settles For $50M 06/18/10 Seattle
Gen-Probe Bets $50M on PacBio 06/17/10 San Francisco
Motricity Lowers IPO Price Range to $10 to $11 06/17/10 Seattle
Trius Gets FDA Clarity 06/16/10 San Diego
GTC Axes 50 Workers, CEO Out 06/16/10 Boston
Motricity, Riding the Mobile Software Wave, Primed for $85M IPO This Week 06/14/10 Seattle
Rib-X Adds $5.5M Debt 06/11/10 Boston
Page 5 of 11 « previous page · next page »